Diverse Genomics Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 2251.31%
- Profit Growth 69.76%
- Ebitda 102.74%
- Net Worth -5.35%
- Total Assets 88.92%
About Diverse Genomics
Diverse Genomics Private Limited (DGPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 July 2014 and has a history of Ten years and six months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saurav Jaiswal, Ankit Panda, and Madhumita Choudhury serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74900WB2014PTC202648
-
Company No.
202648
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Jul 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Diverse Genomics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saurav Jaiswal
|
Director | 23-Jul-2014 | Current |
|
Ankit Panda
|
Director | 11-Aug-2016 | Current |
|
Madhumita Choudhury
|
Director | 01-Aug-2017 | Current |
Financial Performance of Diverse Genomics.
Diverse Genomics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 2251.31% increase. The company also saw a substantial improvement in profitability, with a 69.76% increase in profit. The company's net worth dipped by a decrease of 5.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diverse Genomics?
In 2020, Diverse Genomics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Body N Mind Cafe Private LimitedMadhumita Choudhury is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Diverse Genomics?
Unlock and access historical data on people associated with Diverse Genomics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diverse Genomics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diverse Genomics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
